Brief: Evaxion To Develop Tailored Novel Cancer Vaccines Based Upon A New Untapped Source Of Ai-Discovered Targets

Evaxion A/S

24/01/2024 16:09

Jan 24 (Reuters) - Evaxion Biotech A/S  EVAX.O :
    * EVAXION TO DEVELOP TAILORED NOVEL CANCER VACCINES BASED
UPON A
NEW UNTAPPED SOURCE OF AI-DISCOVERED TARGETS
    * EVAXION BIOTECH A/S: INITIATED PRECLINICAL ACTIVITIES WITH
A
GOAL OF GENERATING PROOF-OF-CONCEPT DATA BY SECOND HALF OF 2024

Source text for Eikon:  ID:nGNXb0Shv2 
Further company coverage:  EVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))